Doxorubicin persistently rewires cardiac circadian homeostasis in mice

Detalhes bibliográficos
Autor(a) principal: Ferreira, Luciana L
Data de Publicação: 2019
Outros Autores: Cervantes, Marlene, Froufe, Hugo J. C., Egas, Conceição, Cunha-Oliveira, Teresa, Sassone-Corsi, Paolo, Oliveira, Paulo J.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/88473
https://doi.org/10.1007/s00204-019-02626-z
Resumo: Circadian rhythms disruption can be the cause of chronic diseases. External cues, including therapeutic drugs, have been shown to modulate peripheral-circadian clocks. Since anthracycline cardiotoxicity is associated with loss of mitochondrial function and metabolic remodeling, we investigated whether the energetic failure induced by sub-chronic doxorubicin (DOX) treatment in juvenile mice was associated with persistent disruption of circadian regulators. Juvenile C57BL/6J male mice were subjected to a sub-chronic DOX treatment (4 weekly injections of 5 mg/kg DOX) and several cardiac parameters, as well as circadian-gene expression and acetylation patterns, were analyzed after 6 weeks of recovery time. Complementary experiments were performed with Mouse Embryonic Fibroblasts (MEFs) and Human Embryonic Kidney 293 cells. DOX-treated juvenile mice showed cardiotoxicity markers and persistent alterations of transcriptional- and signaling cardiac circadian homeostasis. The results showed a delayed influence of DOX on gene expression, accompanied by changes in SIRT1-mediated cyclic deacetylation. The mechanism behind DOX interference with the circadian clock was further studied in vitro, in which were observed alterations of circadian-gene expression and increased BMAL1 SIRT1-mediated deacetylation. In conclusion, DOX treatment in juvenile mice resulted in disruption of oscillatory molecular mechanisms including gene expression and acetylation profiles.
id RCAP_31cc2c32c99cdc42eda154233a95843d
oai_identifier_str oai:estudogeral.uc.pt:10316/88473
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Doxorubicin persistently rewires cardiac circadian homeostasis in miceCardiotoxicity; Chemotherapy; Circadian clock; Doxorubicin; Mitochondria; Protein acetylationCircadian rhythms disruption can be the cause of chronic diseases. External cues, including therapeutic drugs, have been shown to modulate peripheral-circadian clocks. Since anthracycline cardiotoxicity is associated with loss of mitochondrial function and metabolic remodeling, we investigated whether the energetic failure induced by sub-chronic doxorubicin (DOX) treatment in juvenile mice was associated with persistent disruption of circadian regulators. Juvenile C57BL/6J male mice were subjected to a sub-chronic DOX treatment (4 weekly injections of 5 mg/kg DOX) and several cardiac parameters, as well as circadian-gene expression and acetylation patterns, were analyzed after 6 weeks of recovery time. Complementary experiments were performed with Mouse Embryonic Fibroblasts (MEFs) and Human Embryonic Kidney 293 cells. DOX-treated juvenile mice showed cardiotoxicity markers and persistent alterations of transcriptional- and signaling cardiac circadian homeostasis. The results showed a delayed influence of DOX on gene expression, accompanied by changes in SIRT1-mediated cyclic deacetylation. The mechanism behind DOX interference with the circadian clock was further studied in vitro, in which were observed alterations of circadian-gene expression and increased BMAL1 SIRT1-mediated deacetylation. In conclusion, DOX treatment in juvenile mice resulted in disruption of oscillatory molecular mechanisms including gene expression and acetylation profiles.2019-11-25info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/88473http://hdl.handle.net/10316/88473https://doi.org/10.1007/s00204-019-02626-zeng0340-57611432-0738https://link.springer.com/article/10.1007%2Fs00204-019-02626-zFerreira, Luciana LCervantes, MarleneFroufe, Hugo J. C.Egas, ConceiçãoCunha-Oliveira, TeresaSassone-Corsi, PaoloOliveira, Paulo J.info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2021-10-06T10:05:21Zoai:estudogeral.uc.pt:10316/88473Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:09:09.690425Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Doxorubicin persistently rewires cardiac circadian homeostasis in mice
title Doxorubicin persistently rewires cardiac circadian homeostasis in mice
spellingShingle Doxorubicin persistently rewires cardiac circadian homeostasis in mice
Ferreira, Luciana L
Cardiotoxicity; Chemotherapy; Circadian clock; Doxorubicin; Mitochondria; Protein acetylation
title_short Doxorubicin persistently rewires cardiac circadian homeostasis in mice
title_full Doxorubicin persistently rewires cardiac circadian homeostasis in mice
title_fullStr Doxorubicin persistently rewires cardiac circadian homeostasis in mice
title_full_unstemmed Doxorubicin persistently rewires cardiac circadian homeostasis in mice
title_sort Doxorubicin persistently rewires cardiac circadian homeostasis in mice
author Ferreira, Luciana L
author_facet Ferreira, Luciana L
Cervantes, Marlene
Froufe, Hugo J. C.
Egas, Conceição
Cunha-Oliveira, Teresa
Sassone-Corsi, Paolo
Oliveira, Paulo J.
author_role author
author2 Cervantes, Marlene
Froufe, Hugo J. C.
Egas, Conceição
Cunha-Oliveira, Teresa
Sassone-Corsi, Paolo
Oliveira, Paulo J.
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Ferreira, Luciana L
Cervantes, Marlene
Froufe, Hugo J. C.
Egas, Conceição
Cunha-Oliveira, Teresa
Sassone-Corsi, Paolo
Oliveira, Paulo J.
dc.subject.por.fl_str_mv Cardiotoxicity; Chemotherapy; Circadian clock; Doxorubicin; Mitochondria; Protein acetylation
topic Cardiotoxicity; Chemotherapy; Circadian clock; Doxorubicin; Mitochondria; Protein acetylation
description Circadian rhythms disruption can be the cause of chronic diseases. External cues, including therapeutic drugs, have been shown to modulate peripheral-circadian clocks. Since anthracycline cardiotoxicity is associated with loss of mitochondrial function and metabolic remodeling, we investigated whether the energetic failure induced by sub-chronic doxorubicin (DOX) treatment in juvenile mice was associated with persistent disruption of circadian regulators. Juvenile C57BL/6J male mice were subjected to a sub-chronic DOX treatment (4 weekly injections of 5 mg/kg DOX) and several cardiac parameters, as well as circadian-gene expression and acetylation patterns, were analyzed after 6 weeks of recovery time. Complementary experiments were performed with Mouse Embryonic Fibroblasts (MEFs) and Human Embryonic Kidney 293 cells. DOX-treated juvenile mice showed cardiotoxicity markers and persistent alterations of transcriptional- and signaling cardiac circadian homeostasis. The results showed a delayed influence of DOX on gene expression, accompanied by changes in SIRT1-mediated cyclic deacetylation. The mechanism behind DOX interference with the circadian clock was further studied in vitro, in which were observed alterations of circadian-gene expression and increased BMAL1 SIRT1-mediated deacetylation. In conclusion, DOX treatment in juvenile mice resulted in disruption of oscillatory molecular mechanisms including gene expression and acetylation profiles.
publishDate 2019
dc.date.none.fl_str_mv 2019-11-25
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/88473
http://hdl.handle.net/10316/88473
https://doi.org/10.1007/s00204-019-02626-z
url http://hdl.handle.net/10316/88473
https://doi.org/10.1007/s00204-019-02626-z
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0340-5761
1432-0738
https://link.springer.com/article/10.1007%2Fs00204-019-02626-z
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799133984819511296